Is Pharma Building the Right Facilities for Future Biologics?
As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require
False
Advertisement
Related Content
Bioprocessing
Facilities & Equipment
Biopharma
Is Pharma Building the Right Facilities for Future Biologics?
November 9, 2026
5 min read
As biologics portfolios expand and average product volumes fall, Miriam Monge asks whether today’s major manufacturing investments offer the flexibility tomorrow’s market will require
Bioprocessing
Biopharma
Research News
What Will It Take to Control Continuous Biomanufacturing?
November 2, 2026
2 min read
Review examines how PAT, model-based control, reinforcement learning, and digital twins could maintain product quality from perfusion culture through downstream purification
Outsourcing
Choosing a Sterile Fill-Finish Partner
October 22, 2026
5 min read
Alcami’s Kerrie Powell, Senior VP of Sales, discusses the challenges of sterile biologics manufacturing and what sponsors should look for in a CDMO partner
Industry News
Development & Clinical
Regulation & Standards
Can Clinical Trials Collect Less Data Without Compromising Safety?
October 22, 2026
5 min read
Rob DiCicco discusses how FDA–industry collaboration is helping sponsors rethink safety reporting, selective safety data collection, and pragmatic clinical trial design.